enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: ARS
Filing Date: 08 May 2026Report Date: 31 Oct 2025
Accepted: 08 May 2026 02:08 p.m.
Accession Number: 0001140361-26-020034
File Number: 001-41854
Film Number: 26958366